Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder

J Clin Psychopharmacol. 2006 Aug;26(4):444-6. doi: 10.1097/01.jcp.0000227703.72117.bc.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antidepressive Agents, Second-Generation / adverse effects
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Antimanic Agents / therapeutic use
  • Autistic Disorder / drug therapy*
  • Autistic Disorder / psychology
  • Child
  • Double-Blind Method
  • Fluoxetine / adverse effects
  • Fluoxetine / therapeutic use*
  • Humans
  • Irritable Mood / drug effects*
  • Placebos
  • Treatment Outcome
  • Valproic Acid / therapeutic use*

Substances

  • Antidepressive Agents, Second-Generation
  • Antimanic Agents
  • Placebos
  • Fluoxetine
  • Valproic Acid